Free Trial

Synthomer (LON:SYNT) Share Price Crosses Below Two Hundred Day Moving Average - Here's What Happened

Synthomer logo with Basic Materials background

Key Points

  • Synthomer plc's stock price has fallen below its 200-day moving average, trading at GBX 66 ($0.89), significantly lower than the average of GBX 102.07 ($1.38).
  • Analysts have a consensus rating of "Hold" for Synthomer, with a consensus price target of GBX 142.50, though several brokerages have recently adjusted their price objectives downwards.
  • Insiders have been actively buying shares, with two executives purchasing a total of 45,000 shares at an average price of GBX 64 each recently.
  • Want stock alerts on Synthomer? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Synthomer plc (LON:SYNT - Get Free Report) shares crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 102.07 ($1.38) and traded as low as GBX 63.32 ($0.85). Synthomer shares last traded at GBX 66 ($0.89), with a volume of 338,479 shares changing hands.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on SYNT. Jefferies Financial Group restated a "hold" rating and issued a GBX 100 target price on shares of Synthomer in a report on Tuesday, August 5th. Berenberg Bank reduced their target price on Synthomer from GBX 120 to GBX 80 and set a "hold" rating for the company in a report on Wednesday, August 6th. Finally, Deutsche Bank Aktiengesellschaft reduced their target price on Synthomer from GBX 140 to GBX 115 and set a "hold" rating for the company in a report on Wednesday, July 30th. One investment analyst has rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, Synthomer presently has a consensus rating of "Hold" and a consensus price target of GBX 142.50.

Read Our Latest Research Report on SYNT

Synthomer Trading Down 2.7%

The company has a debt-to-equity ratio of 78.27, a current ratio of 1.90 and a quick ratio of 0.97. The company has a fifty day moving average of GBX 84.40 and a 200-day moving average of GBX 100.34. The firm has a market capitalization of £99.06 million, a PE ratio of -136.49, a price-to-earnings-growth ratio of -0.17 and a beta of 1.79.

Synthomer (LON:SYNT - Get Free Report) last posted its earnings results on Tuesday, August 5th. The company reported GBX (5.40) earnings per share for the quarter. Synthomer had a negative net margin of 4.40% and a negative return on equity of 7.52%. On average, sell-side analysts anticipate that Synthomer plc will post 12.962963 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, insider Jonathan Silver bought 59,229 shares of the business's stock in a transaction on Wednesday, August 6th. The shares were bought at an average cost of GBX 65 per share, for a total transaction of £38,498.85. Also, insider Lily Liu bought 20,000 shares of the business's stock in a transaction on Tuesday, August 5th. The shares were bought at an average price of GBX 64 per share, for a total transaction of £12,800. Insiders have purchased 124,149 shares of company stock valued at $8,701,965 in the last three months. 4.93% of the stock is currently owned by corporate insiders.

About Synthomer

(Get Free Report)

Synthomer plc is a leading supplier of high-performance, highly specialised polymers and ingredients that play vital roles in key sectors such as coatings, construction, adhesives, and health and protection – growing markets for customers who serve billions of end users worldwide. Headquartered in London, UK and listed on the LSE since 1971, we employ c.3,900 employees across our five innovation centres of excellence and 29 manufacturing sites across Europe, North America, Middle East and Asia.

Featured Articles

Should You Invest $1,000 in Synthomer Right Now?

Before you consider Synthomer, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synthomer wasn't on the list.

While Synthomer currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

$15 Billion for Cybersecurity: The Government’s Next Big Push
Tesla’s Future Unleashed: Elon’s Robotics Move Changes Everything
Top Trades: Massive Gains and Costly Mistakes to Avoid

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines